Search

Author/Creator Tuscano, Joseph

2. Targeted therapy with MXD3 siRNA, anti‐CD22 antibody and nanoparticles for precursor B‐cell acute lymphoblastic leukaemia. (8th September 2014)

Authors:
Satake, Noriko; Duong, Connie; Chen, Cathy; Barisone, Gustavo A.; Diaz, Elva; Tuscano, Joseph; Rocke, David M.; Nolta, Jan; Nitin, Nitin
Journal:
British journal of haematology
Issue:
Volume 167:Number 4(2014:Nov.)
Page Start:
487
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Orbital Rosai–Dorfman Disease Presenting as Optic Neuritis. Issue 1 (March 2022)

Authors:
Virk, Harjot S.; Shahlaie, Kiarash; Ramani, Biswarathan; Perry, Arie; Fragoso, Ruben; Tuscano, Joseph; Liu, Yin A.
Other Names:
Avery Robert section editor.; Golnik Karl C. section editor.; Froment Caroline section editor.; Wang An-Guor section editor.
Journal:
Journal of neuro-ophthalmology
Issue:
Volume 42:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study. (21st September 2016)

Authors:
Kirschbaum, Mark H.; Frankel, Paul; Synold, Timothy W.; Zain, Jasmine; Claxton, David; Tuscano, Joseph; Newman, Edward M.; Gandara, David R.; Lara, Primo N.
Journal:
British journal of haematology
Issue:
Volume 180:Number 3(2018)
Page Start:
445
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗